Adverum Biotechnologies Inc. Stock
We see a rather positive sentiment for Adverum Biotechnologies Inc. with 6 Buy predictions and 1 Sell predictions.
With a target price of 4 € there is potential for a 189.86% increase which would mean more than doubling the current price of 1.38 € for Adverum Biotechnologies Inc..
So far the community has only identified positive things for Adverum Biotechnologies Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Adverum Biotechnologies Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adverum Biotechnologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 3.710% | 0.436% | -11.361% | 47.951% | 3.668% | -1.770% | - |
| Salarius Pharmaceuticals Inc. | -2.830% | -4.072% | 0.000% | -70.556% | -23.604% | -98.430% | -99.993% |
| Brainstorm Cell | -30.000% | -29.447% | -33.143% | -87.283% | 51.293% | -87.897% | - |
Comments
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.
Show more
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Mizuho from $40.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ADVM provided by MarketBeat
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Show more
Ratings data for ADVM provided by MarketBeat